National Comprehensive Cancer Network

About NCCN

NCCN Oncology Policy Program Updates

On Monday, June 27, 2016, the National Comprehensive Cancer Network® (NCCN®) convened the first policy summit of 2016 in Washington, DC, titled, Emerging Issues and Opportunities in Health Information Technology. Moderated by Clifford Goodman, PhD, The Lewin Group, the summit brought together key stakeholders in health information technology (HIT) including clinicians, clinical and translational investigators, hospitals, pharmaceutical and device industry, HIT companies and vendors, federal agencies, and patient advocacy groups. Speakers and roundtable panel members explained the increasing demands for HIT to improve the quality of cancer care, identified areas of concern in the access of cancer care, examined the Cancer Moonshot Initiative, and thoughtfully discussed improving HIT as it related to health outcomes. A final white paper on the policy summit will be published in JNCCNJournal of the National Comprehensive Cancer Network and a brief summary will be posted on the NCCN Oncology Policy Program webpage.

NCCN recently responded to the Request for Information (RFI) regarding assessing interoperability for the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Interoperable electronic health record (EHR) technology has great significance for the many people with cancer worldwide who benefit from NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and derivative products. As an alliance of 27 leading academic cancer centers in the United States, NCCN is a developer of authoritative information regarding cancer prevention, screening, diagnosis, treatment, and supportive care that is widely used by clinical professionals. Read NCCN's full statement here.

The NCCN Oncology Policy Program was initiated in 2009 to allow opportunities for discussion among oncology stakeholders to address relevant health policy concerns. NCCN collaborates with policy experts and leverages expertise at NCCN Member Institutions to ensure NCCN plays a visible advocacy role, effectively influencing policy discussion about quality, outcomes, and value for cancer care. In light of the quickly changing policy landscape as a result of recent reforms, such as MACRA, NCCN recognized the need to expand the NCCN Oncology Policy Program and has hired Lisa Lentz, the new Director of Policy and Quality, and Donna Moncuso, the new Director of Payer and Employer Outreach. Additionally, a newly hired Policy/Advocacy Fellow, Katy Winckworth-Prejsnar, will join the Quality of Care Fellow, Liz Nardi, to research, develop, advocate, facilitate, and communicate the implementation of oncology policy that furthers NCCN’s mission to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives and NCCN's vision to be the world’s leader in defining and advancing high-quality, high-value cancer care. Moving forward, the NCCN Oncology Policy Program will provide regular updates on upcoming policy summits, RFI comments, NCCN advocacy efforts, and additional policy/advocacy recommendations.

Please check back often for additional updates regarding this program. If you have any questions, please contact Katy Winckworth-Prejsnar.